These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 460097)

  • 1. [Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)].
    Castello D; Costa G; De Candussio G
    Minerva Pediatr; 1979 Mar; 31(5):371-80. PubMed ID: 460097
    [No Abstract]   [Full Text] [Related]  

  • 2. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction.
    Edwards GF; Steel AE; Scott JK; Jordan JW
    Chest; 1976 Oct; 70(4):506-13. PubMed ID: 789027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of the clinical effectiveness of the mucolytic drug, S-carboxymethylcysteine, in the therapy of acute and chronic bronchitis].
    Magliulo E; Bonizzoni D; Cattaneo E; Scevola D; Concia E
    Minerva Med; 1975 Apr; 66(25):1187-97. PubMed ID: 1134660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Optimal use of expectorants (current trends)].
    Mirrakhimov MM; Brimkulov NN; Rafibekova ZhS
    Ter Arkh; 1981; 53(1):110-7. PubMed ID: 7013137
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carbocysteine in the treatment of recurrent bronchitis in infants].
    Bánovcin P; Jakusová L; Rösslerová V; Miklerová M; Pullmann R
    Cesk Pediatr; 1992 Sep; 47(9):543-6. PubMed ID: 1394568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
    Silvia G; Giambrone F; Battaglia E; Romano M
    G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue.
    Braga PC; Scaglione F; Scarpazza G; Fraticelli G; Roviaro G; Varoli F; Mariani C; Falchi M; Fraschini F
    Int J Clin Pharmacol Res; 1985; 5(5):331-40. PubMed ID: 4066083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
    Thomson ML; Pavia D; Jones CJ; McQuiston TA
    Thorax; 1975 Dec; 30(6):669-73. PubMed ID: 769242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucodine in the treatment of chronic bronchitis].
    Wierzbicka M; Wójcik RA
    Pneumonol Pol; 1981; 49(5):369-76. PubMed ID: 7022385
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis.
    Braga PC; Borsa M; De Angelis L; Bossi R; Allegra L; Scaglione F; Scarpazza G
    Clin Ther; 1982; 4(6):480-8. PubMed ID: 7093981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control.
    Grillage M; Barnard-Jones K
    Br J Clin Pract; 1985 Oct; 39(10):395-8. PubMed ID: 3907681
    [No Abstract]   [Full Text] [Related]  

  • 12. s-Carboxy-methyl-cysteine syrup in secretory otitis media.
    Taylor PH; Dareshani N
    Br J Clin Pract; 1975 Jul; 29(7):177-8, 180. PubMed ID: 1103927
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of S-carboxymethylcysteine on tracheal mucus velocity.
    Goodman RM; Yergin BM; Sackner MA
    Chest; 1978 Dec; 74(6):615-8. PubMed ID: 367726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carbocysteine in the treatment of secretory tubotympanic catarrh in childhood].
    Kaspárek L; Vránová M; Sejna I
    Cesk Otolaryngol; 1988 Dec; 37(6):364-8. PubMed ID: 3233668
    [No Abstract]   [Full Text] [Related]  

  • 15. Carboxymethylcysteine in the glue ear syndrome.
    McGuiness RJ
    Br J Clin Pract; 1977; 31(7-8):105-6. PubMed ID: 921885
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inhalation and peroral mucolytic therapy in mucoviscidosis in children].
    Uglitskikh AK; Khan MA; Sharapov SV; Kapranov NI; Plisko LF
    Vopr Kurortol Fizioter Lech Fiz Kult; 1996; (5):15-8. PubMed ID: 9036657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of the effectiveness of lasolvan and mucodine in chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Sov Med; 1988; (5):69-72. PubMed ID: 3062806
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of mukodin on indices of mucociliary transport].
    Solopov VN; Lunichkina IV; Plisko LF; Kolganova NA
    Ter Arkh; 1988; 60(12):55-7. PubMed ID: 3247655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of bronchitic syndrome using Transbronchin in the practice].
    Plietz J
    ZFA (Stuttgart); 1976 Dec; 52(35):1832-4. PubMed ID: 797159
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine].
    Henocq A; Moreau C; Mallet E; Sauger F; de Menibus CH
    Ann Otolaryngol Chir Cervicofac; 1985; 102(5):373-5. PubMed ID: 4037622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.